Safely Buy Vascepa ( Icosapent Ethyl ) from Canada Prescriptions Plus.

Indications

Vascepa (icosapent ethyl) is a prescription medication for reducing the incidence of cardiovascular events such as heart attack and stroke.

Vascepa is typically prescribed for patients with high triglyceride levels and is administered in combination with other medications, such as statins.

Vascepa works differently from other omega-3 medications as it is a highly purified form of eicosapentaenoic acid (EPA) that is believed to have a more significant effect on reducing cardiovascular risks.

Use and Dosage

Usual Adult Dose for Hypertriglyceridemia:

2 g orally twice a day with food

• Comments: Limitations of Use: The effect of this drug on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.
• Uses:
  • As an adjunct to diet to reduce triglyceride (TG) levels in patients with severe (500 mg/dL or greater) hypertriglyceridemia
  • As an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in patients with elevated TG levels (150 mg/dL or higher) and: established cardiovascular disease OR diabetes mellitus and at least 2 additional risk factors for cardiovascular disease

Usual Adult Dose for Cardiovascular Risk Reduction:

2 g orally twice a day with food

• Comments:
  • Limitations of Use: The effect of this drug on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.
• Uses:
  • As an adjunct to diet to reduce triglyceride (TG) levels in patients with severe (500 mg/dL or greater) hypertriglyceridemia
  • As an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in patients with elevated TG levels (150 mg/dL or higher) and: established cardiovascular disease OR diabetes mellitus and at least 2 additional risk factors for cardiovascular disease

Side Effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Serious side effects include:

• Fast or irregular heartbeats, dizziness, shortness of breath, chest discomfort, fainting, or if you feel light-headed
• Serious bleeding

Common side effects of icosapent include:

• Muscle or joint pain
• Constipation
• Swelling of the hands, legs, or feet
• Gout
• Chest pressure, racing or pounding heartbeats, fluttering in your chest, feeling short of breath

This is not a complete list of side effects and others may occur.

Cautions

You should not use icosapent if you are allergic to it.

Tell your doctor if you have ever had:

• Liver disease
• Diabetes
• A thyroid disorder
• Problems with your pancreas
• A bleeding or blood-clotting disorder
• If you are allergic to fish or shellfish

It is not known whether icosapent will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Icosapent can pass into breast milk and may harm your baby. Tell your doctor if you are breastfeeding.

Icosapent is not approved for use by anyone younger than 18 years old.

Form and Strengths

Vascepa is available in the following form and strengths:

Vascepa Capsule:

• 1 g

FAQ

How should I take icosapent?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

What happens if I miss a dose?

Take the medicine as soon as you can but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention.

What should I avoid while taking icosapent?

Avoid eating foods that are high in fat or cholesterol. Icosapent will not be as effective in lowering your cholesterol if you do not follow a cholesterol-lowering diet plan.

Resources:

1. https://www.drugs.com/mtm/icosapent.html#dosage
2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf
3. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c1a2828-1583-4414-ab22-a60480e8e508